-- Enrollment in the phase 2 study of acazicolcept in systemic lupus erythematosus (Synergy) will be stopped to allow for early assessment of data --
-- Final analysis after last patient completes study protocol expected to occur by the end of 2024 --
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.